Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Odiparcil for VTE prevention after total knee replacement
NCT00244725Phase 2Completed
- Sponsor
- GSK
- Start
- Sep 2005
- Primary completion
- Sep 2006
- Countries
- 13
01
Overview
A Phase 2 trial of odiparcil in venous thromboembolism (VTE), sponsored by GSK. Started Sep 2005; status: completed.
02
Drugs
odiparcil
03
Conditions
venous thromboembolism (VTE)
Beyond the preview
Go deeper on NCT00244725.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00244725.